Pfizer and Flynn Pharma, manufacturers of phenytoin sodium capsules which are used to treat epilepsy, have been fined a combined total of £69 million by the Competitions Appeal Tribunal (CAT) for ...

In a provisional judgment, the CMA has concluded that Pfizer and Flynn abused a dominant position to overcharge the NHS for phenytoin sodium capsules, causing NHS spending on the drug to balloon ...

An appeal tribunal has upheld almost £70m in fines for two companies’ “illegal behaviour” that upped NHS spending on ...

In a judgment handed down on Wednesday, the U.K.’s Competition Appeal Tribunal found that Pfizer (PFE) and Flynn abused their dominant ...